Depomed, Inc. (NASDAQ: DEPO), a specialty pharmaceutical company, is devoted to enhancing existing pharmaceutical products. To date, the company has brought two products to market and has developed a pipeline with late-stage product opportunities designed to address common medical conditions. Depomed’s core delivery technology, AcuForm, is a patented, polymer-based technology that improves delivery through gastric retention. For further information, visit the Company’s web site at www.depomedinc.com.
- 17 years ago
QualityStocks
Depomed, Inc. (NASDAQ: DEPO)
Tags Rodman & Renshaw
Related Post
-
Beeline Holdings Inc. (NASDAQ: BLNE) Bullish About Millennials and Gen Z Lendable Market; Floats AI-Powered Mortgage and Loans Product
Beeline Holdings Inc. continues to see growing opportunities in the millennials and Gen Z market…
-
Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positioned to Capitalize on Rising Market Demand
The surge in platinum group metal prices can be traced to a combination of supply…
-
Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ): Alaska’s Role Expands in Critical Minerals Security
U.S. government exploring creation of a $5 billion critical minerals fund amid supply chain concerns…